Studies on red cell aplasia. 3. Treatment with horse antihuman thymocyte gamma globulin.
D000741:Anemia, Aplastic / Q000188:drug therapy* / Q000276:immunology; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001854:Bone Marrow Cells; D002478:Cells, Cultured; D002848:Chromatography, DEAE-Cellulose; D003520:Cyclophosphamide / Q000627:therapeutic use; D003601:Cytotoxicity Tests, Immunologic; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D005455:Fluorescent Antibody Technique; D006418:Heme / Q000096:biosynthesis; D006736:Horses; D006801:Humans; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000032:analysis; D007165:Immunosuppression Therapy; D007503:Iron Isotopes; D007958:Leukocyte Count; D008875:Middle Aged; D012756:Sheep; D013950:Thymus Gland / Q000166:cytology / Q000276:immunology; D014461:Ultracentrifugation; D005719:gamma-Globulins / Q000627:therapeutic use*
D000906:Antibodies; D000961:Antilymphocyte Serum; D007074:Immunoglobulin G; D007503:Iron Isotopes; D005719:gamma-Globulins; D004921:Erythropoietin; D006418:Heme; D003520:Cyclophosphamide